Unmet need in the treatment of multiple myeloma in Thailand: early mortality predicted by older age and high β2-microglobulin

Rajkumar SV. Multiple myeloma: 2022 update on diagnosis, risk-stratification and management. Am J Hematol. 2022;97:1086-107.

Kyle RA, Gertz MA, Witzig TE, Lust JA, Lacy MQ, Dispenzieri A, et al. Review of 1,027 patients with newly diagnosed multiple myeloma. Mayo Clinic Proc. 2003;78:21-33.

Kumar SK, Dispenzieri A, Lacy MQ, Gertz MA, Buadi FK, Pandey S, et al. Continued improvement in survival in multiple myelo ma: changes in early mortality and outcomes in older patients. Leukemia. 2014;28:1122-8.

Kumar V, Ailawadhi M, Dutta N, Abdulazeez M, Aggarwal CS, Quintero G, et al. Trends in early mortality from multiple my eloma: a population-based analysis. Clin Lymphoma Myeloma Leuk. 2021;21:e449-5.

Grant SJ, Wildes TM, Rosko AE, Silberstein J, Giri S. A real-world data analysis of predictors of early mortality after a diagnosis of multiple myeloma. Cancer. 2023;129:2023-34.

Augustson BM, Begum G, Dunn JA, Barth NJ, Davies F, Morgan G, et al. Early mortality after diagnosis of multiple myeloma: analysis of patients entered onto the United Kingdom Medical Research Council trials between 1980 and 2002--Medical Research Council Adult Leukaemia Working Party. J Clin Oncol. 2005;23:9219-26.

Rotchanapanya W, Pongsuthiyakorn V. Factors associated with early outcomes of multiple myeloma: a 10-year retrospective study in Chiangrai Prachanukroh hospital. Chiangrai Med J. 2022;14:33-43